You are here:

Reducing Temporary Work Absence Through Early Intervention: The case of MSDs in the EU

The case for early interventions
Reducing Temporary Work Absence Through Early Intervention: The case of MSDs in the EU
21 October 2013

With many EU member states set to see 50% of their population diagnosed with an MSD by 2030, this report warns that this growing problem cannot be ignored and must be urgently addressed.

MSDs are the leading cause of sickness absence across the EU -44 million workers have MSDs – including back pain and strains of the neck, shoulder and arms. This costs up to €240bn annually in lost productivity and sickness absence, representing up to  2% of GDP across the EU. The report calls on EU member states to coordinate action between government departments, employers and clinicians to tackle this problem and save billions while transforming the lives of those affected by such devastating conditions.